Interleukin-1β regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 276-282

  Lapointe, Margot C ^a   Isenović, Esma ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Cell signaling; Nitric oxide; Phospholipases; Prostaglandins

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; NITRIC OXIDE SYNTHASE; PHOSPHOLIPASE; PROSTAGLANDIN E2; RNA; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENZYME INHIBITOR; FLAVONOID; IMIDAZOLE DERIVATIVE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NOS2 PROTEIN, RAT; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE (CALCIUM,CALMODULIN); PYRIDINE DERIVATIVE;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME REGULATION; HEART MUSCLE CELL; IMMUNOREGULATION; NEWBORN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HEART; HEART MUSCLE; HEART VENTRICLE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; CYCLOOXYGENASE 2; ENZYME INHIBITORS; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEART; HEART VENTRICLES; IMIDAZOLES; INTERLEUKIN-1; ISOENZYMES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 0032617299     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.276     Document Type: Article

References (50)

1. Morris SM Jr, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol. 1994;266:E829-E839.
2. Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide regulation: potential relevance to cardiovascular disease. Circ Res. 1993;73:217-222.
3. Ungureanu-Longrois D, Balligand J-L, Kelly RA, Smith TW. Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol. 1995;27:155-167.
4. Wong SCY, Fukuchi M, Melnyk P, Rodger I, Giaid A. Induction of cyclooxygenase-2 and activation of nuclear factor-κB in myocardium of patients with congestive heart failure. Circulation. 1998;98:100-103.
5. Herskowitz A, Choi S, Ansari A, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol. 1995; 146:419-428.
6. Shioi T, Matsumori A, Kihara Y, Inoko M, Ono K, Iwanaga Y, Yamada T, Iwasaki A, Matsushima K, Sasayama S. Increased expression of interleukin-1β and monocyte chemotactic and activating factor/monocyte chemoattractant prolein-1 in the hypertrophied and failing heart with pressure overload. Circ Res. 1997;81:664-671.
7. LaPointe MC, Sitkins JR. Mechanisms of interleukin-1β regulation of nitric oxide synthase in cardiac myocytes. Hypertension. 1996;27: 709-714.
8. 2 metabolites regulate inducible nitric oxide synthase in myocytes. Hypertension. 1998;31:218-224.
9. 2. J Biol Chem. 1998;273:14411-14423.
10. 2. Proc Natl Acad Sci U S A. 1998; 95:7951-7956.
11. Appleton I, Tomlinson A, Willoughby DA. Induction of cyclooxygenase and nitric oxide synthase in inflammation. Adv Pharmacol. 1996;35: 27-78.
12. Chiariello M, Ambrosio G, Cappelli-Bigazzi M, Nevola E, Perrone-Filardi P, Maone G, Condorelli M. Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion. J Pharmacol Exp Ther. 1987;241: 560-568.
13. 2 and C in myocardial ischemic reperfusion injury. Am J Physiol. 1991;260:H877-H883.
14. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell. 1994; 76:253-262.
15. Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 1994;77:325-328.
16. Reddy SAG, Huang JH, Liao WS-L. Phosphatidylinositol 3-kinase in interleukin 1 signaling: physical interaction with the interleukin 1 receptor and requirement in NFκB and AP-I activation. J Biol Chem. 1997;272:29167-29173.
17. Kyriakis JM, Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays. 1996;18:567-577.
18. Huwiler A, Pfeilschifter J. Interleukin-1 stimulates de novo synthesis of mitogen-activated protein kinase in glomerular mesangial cells. FEBS Lett. 1994;350:135-138.
19. Fanger GR, Gerwins P, Widmann C, Jarpe MB, Johnson GL. MEKKs, GCKs, MLKs, PAKs, TAKs, and Tpls. Upstream regulators of the c-Jun amino-terminal kinase. Curr Opin Genet Dev. 1997;7:67-74.
20. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW, Strickler JE, McLaughlin MM, Siemens IR, Fisher SM, Livi GP, White JR, Adams JL, Young PR. A protein kinase involved in regulation of inflammatory cytokine biosynthesis. Nature. 1994;372:739-746.
21. Pouliot M, Baillargeon J, Lee JC, Cleland LG, James MJ. Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase. J Immunol. 1997;158:4930-4937.
22. 2 biosynthesis stimulated by interleukin-1β. J Biol Chem. 1997;272:8083-8089.
23. Ridley SH, Sarsfield SJ, Lee JC, Bigg HF, Cawston TE, Taylor DJ, DeWitt DL, Saklatvala J. Actions of IL-1 are selectively controlled by p38 mitogen-activated kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J Immunol. 1997;158: 3165-3173.
24. 2. J Biol Chem. 1994;269:13057-13060.
25. 2. J Biol Chem. 1997;272:16709-16712.
26. Stella N, Estelles A, Siciliano J, Tence M, Desagher S, Piomelli D, Glowinski J, Premont J. Interleukin-1 enhances the ATP-evoked release of arachidonic acid from mouse astrocytes. J Neurosci. 1997;17: 2939-2946.
27. LaPointe MC, Sitkins JR. Phorbol ester stimulates the synthesis and secretion of brain natriuretic peptide (BNP) from cultured neonatal rat ventricular cardiocytes: a comparison with the regulation of atrial natriuretic factor (ANF). Mol Endocrinol. 1993;7:1284-1296.
28. Harding P, Carretero OA, LaPointe MC. Effects of interleukin-1β and nitric oxide on cardiac myocytes. Hypertension. 1995;25:421-430.
29. 2 by p38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem. 1997;245:751-759.
30. 2 in rat renal mesangial cells. Biochim Biophys Acta. 1997;1348:257-272.
31. 2 in the human astrocytoma cell line 1321N1. J Biol Chem. 1998;273:606-612.
32. Bhat NR, Zhang P, Lee JC, Hogan EL. Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-α gene expression in endotoxin-stimulaled primary glial cultures. J Neurosci. 1998;18:1633-1641.
33. Larsen CM, Wadt KAW, Juhl LF, Andersen HU, Karlsen AE, Su M, Seedorf K, Shapiro L, Dinarello CA, Mandrup-Poulsen T. Interleukin-1β-induced rat pancreatic islet nitric oxide synthesis requires both the p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J Biol Chem. 1998;273:15294-15300.
34. Kleinen H, Euchenhofer C, Fritz G, Ihrig-Biedert I, Forstermann U. Involvement of protein kinases in the induction of NO synthase II in human DLD-1 cells. Br J Pharmacol. 1998;123:1716-1722.
35. Hwang D, Jang BC, Yu G, Boudreau M. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-κB signaling pathways in macrophages. Biochem Pharmacol. 1997;54:87-96.
36. Xie Q-W, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon γ and bacterial lipopolysaccharide. J Exp Med. 1993;177: 1779-1784.
37. Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc Natl Acad Sci U S A. 1993;90:9730-9734.
38. Xie Q-W, Kashiwabara Y, Nathan C. Role of transcription factor NFκB/rel in induction of nitric oxide synthase. J Biol Chem. 1994;269: 4705-4708.
39. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, Shapiro D, Le J, Koh SI, Kimura T, Green SJ, Mak TW, Taniguchi T, Vilcek J. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 1994;263:1612-1615.
40. Spink J, Cohen J, Evans TJ. The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase: activation by nuclear factor-κB. J Biol Chem. 1995;270:29541-29547.
41. Kinugawa K, Shimizu T, Yao A, Kohmoto O, Serizawa T, Takahashi T. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal cardiac myocytes. Circ Res. 1997;81:911-921.
42. Kosaka T, Miyata A, Ihara H, Hara S, Sugimoto T, Takeda O, Takahashi E, Tanabe T. Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem. 1994;221: 889-897.
43. Xie W, Fletcher BS, Andersen RD, Herschman HR. V-src induction of the TIS10/PGS2 prostaglandin synthase gene is mediated by an ATF/CRE transcription response element. Mol Cell Biol. 1994;14: 6531-6539.
44. Yamamoto K, Arakawa T, Ueda N, Yamamoto S. Transcriptional roles of nuclear factor KB and nuclear factor-interleukin-6 in the tumor necrosis factor α-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J Biol Chem. 1995;270:31315-31320.
45. Xie W, Herschman HR. Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J Biol Chem. 1996;271:31742-31748.
46. Thuerauf D, Arnold ND, Zechner D, Hanford DS, DeMartin KM, McDonough PM, Prywes R, Glembotski CC. p38 mitogen-activated protein kinase mediates the transcriptional induction of the atrial natriuretic factor gene through a serum response element: a potential role for the transcription factor ATF6. J Biol Chem. 1998;273:20636-20643.
47. 2 is phosphorylated and activated by MAP kinase. Cell. 1993;72:269-278.
48. 2. J Biol Chem. 1997;272:19891-19897.
49. 2 generation in rat 3Y1 fibroblasts. J Biol Chem. 1998;273:1733-1740.
50. Wang D, Yang X-P, Liu Y-H, Carretero OA, LaPointe MC. Reduction of myocardial infarct size by inhibition of inducible nitric oxide synthase. Am J Hypertens. In press.